Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
25.0%
% of CANC's 48 holdings also in BBP
19.7%
% of BBP's 65 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
BEIGENE LTD. SPONSORED ADR | 2.7% | 2.3% | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.0% | 2.2% | 2.2% |
|
AMGEN INC | 2.6% | 2.0% | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 4.4% | 1.9% | 1.9% |
|
EXELIXIS INC | 3.8% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBP
|
REVOLUTION MEDICINES, INC. | 5.7% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
ELI LILLY & CO | 4.9% |
 |
ASTRAZENECA PLC | 4.1% |
|
NOVARTIS AG | 4.1% |
|
SUMMIT THERAPEUTICS INC | 4.1% |
|
NUVALENT, INC. CLASS A | 3.9% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% |
 |
GENMAB A/S SPONSORED ADR | 3.5% |
 |
MERUS N.V. | 3.0% |
CANC Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
PTC THERAPEUTICS INC | -1.8% |
|
DYNAVAX TECHNOLOGIES CORP | -1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.8% |